KPC Pharmaceuticals Inc (600422)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:KPC Pharmaceuticals Inc (600422) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014119
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:32
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
KPC Pharmaceuticals Inc (KPC), formerly Kunming Pharmaceutical Corp, a subsidiary of Holley Group Co Ltd, is a manufacturer of botanical drugs and other pharmaceutical products. The company offers panax notoginseng, gastrodine, artemether and botanical drugs. It also offers drugs such as xuesaitong Injection, xuesaitong soft capsules, xuesaitong freeze-dried powder for injection, gastrodin capsules, acetagastrodin tablets, gastrodin tablets, colchicines tablet, fibrauretine tablets and injection, and breviscapine tablets, among others. KPC conducts research and development to develop new drugs. The company’s drugs are used for central nervous system disorder, cardiovascular disorders and malaria. It markets its products through its partners across the world. KPC is headquartered in Kunming, China.

KPC Pharmaceuticals Inc (600422) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
KPC Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
KPC Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
KPC Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
KPC Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
KPC Pharmaceuticals Inc, Medical Devices Deals, 2011 to YTD 2017 9
KPC Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
KPC Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Rani Therapeutics Raises Funds in Financing 12
Partnerships 14
KPC Pharma to Form Joint Venture 14
Kunming Pharma Forms Joint Venture With Uzfarmprom State Joint Stock Company 15
Kunming Pharma Enters Into Co-Development Agreement With Heilongjiang ZBD Pharma 16
Equity Offering 17
KPC Pharma Receives Approval for Private Placement of Shares 17
Kunming Pharma Plans to Raise USD203 Million in Private Placement Of Shares 18
Kunming Pharma Announces Public Offering Of Shares For US$110 Million 19
Debt Offering 20
KPC Pharma to Raise USD48 Million in Public Offering of Bonds 20
Kunming Pharma Plans to Raise USD49 Million in Public Offering of Bonds 21
Acquisition 22
KPC Pharma Plans to Acquire 60% Stake in Dali Based Pharma Company for USD2.7 Million 22
KPC Pharma to Acquire 60% Stake in Yun’nan-Based Pharma Company for USD3 Million 23
KPC Pharma to Acquire 70% Stake in Zhejiang Holley Nanhu Pharma from Beijing Holley-Cotec Pharma for USD4 Million 24
KPC Pharma Acquires 70% Stake in Beijing Hua Fang Ketai Pharma for USD39 Million 25
KPC Pharma Plans to Acquire Chongqing based Pharma Company from Beijing based Medical Company for USD8 Million 26
KPC Pharma Plans to Acquire Beijing based Pharma Company for USD1.4 Million 27
KPC Pharma Acquires 49% Stake in Kunming-based Pharma Company from Kunming Baker Norton Pharma for USD48 Million 28
KPC Pharma to Acquire Stake in Rani Therapeutics for USD5 Million 29
KPC Pharmaceuticals Inc – Key Competitors 30
KPC Pharmaceuticals Inc – Locations And Subsidiaries 31
Head Office 31
Other Locations & Subsidiaries 31
Joint Venture 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32

List of Tables
KPC Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
KPC Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
KPC Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
KPC Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
KPC Pharmaceuticals Inc, Deals By Therapy Area, 2011 to YTD 2017 8
KPC Pharmaceuticals Inc, Medical Devices Deals, 2011 to YTD 2017 9
KPC Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Rani Therapeutics Raises Funds in Financing 12
KPC Pharma to Form Joint Venture 14
Kunming Pharma Forms Joint Venture With Uzfarmprom State Joint Stock Company 15
Kunming Pharma Enters Into Co-Development Agreement With Heilongjiang ZBD Pharma 16
KPC Pharma Receives Approval for Private Placement of Shares 17
Kunming Pharma Plans to Raise USD203 Million in Private Placement Of Shares 18
Kunming Pharma Announces Public Offering Of Shares For US$110 Million 19
KPC Pharma to Raise USD48 Million in Public Offering of Bonds 20
Kunming Pharma Plans to Raise USD49 Million in Public Offering of Bonds 21
KPC Pharma Plans to Acquire 60% Stake in Dali Based Pharma Company for USD2.7 Million 22
KPC Pharma to Acquire 60% Stake in Yun'nan-Based Pharma Company for USD3 Million 23
KPC Pharma to Acquire 70% Stake in Zhejiang Holley Nanhu Pharma from Beijing Holley-Cotec Pharma for USD4 Million 24
KPC Pharma Acquires 70% Stake in Beijing Hua Fang Ketai Pharma for USD39 Million 25
KPC Pharma Plans to Acquire Chongqing based Pharma Company from Beijing based Medical Company for USD8 Million 26
KPC Pharma Plans to Acquire Beijing based Pharma Company for USD1.4 Million 27
KPC Pharma Acquires 49% Stake in Kunming-based Pharma Company from Kunming Baker Norton Pharma for USD48 Million 28
KPC Pharma to Acquire Stake in Rani Therapeutics for USD5 Million 29
KPC Pharmaceuticals Inc, Key Competitors 30
KPC Pharmaceuticals Inc, Subsidiaries 31
KPC Pharmaceuticals Inc, Joint Venture 31

★海外企業調査レポート[KPC Pharmaceuticals Inc (600422)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Southern California Gas Co:企業の戦略的SWOT分析
    Southern California Gas Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • NeuroGenetic Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary NeuroGenetic Pharmaceuticals Inc (NeuroGenetic Pharmaceuticals) is a pharmaceutical company that develops drugs for Alzheimer’s diseases. The company develops products with its gamma-secretase modulators technology. It applies multiple lead compounds for the treatment of neurodegenerative co …
  • Ball Aerospace & Technologies Corp.:企業の戦略・SWOT・財務情報
    Ball Aerospace & Technologies Corp. - Strategy, SWOT and Corporate Finance Report Summary Ball Aerospace & Technologies Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • GridPoint, Inc.-エネルギー分野:企業M&A・提携分析
    Summary GridPoint, Inc. (Gridpoint), a subsidiary of Twenty First Century Utilities LLC, is a provider of data-driven energy management systems. The company offers a wide range of energy management hardware including control, equipment-level sub-metering and advanced monitoring devices such as contr …
  • eFFECTOR Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary eFFECTOR Therapeutics Inc (eFFECTOR) is a clinical-stage biopharmaceutical company that focuses on the discovery and development of selective translation regulators for the treatment of cancer. Its investigational compounds are designed to restore the translational control of processes that …
  • NovImmune SA:製薬・医療:M&Aディール及び事業提携情報
    Summary NovImmune SA (NovImmune) is a biopharmaceutical company that discovers and develops antibody-based drugs for the treatment of inflammatory diseases, immune-related disorders and cancer. The company develops pipeline products using its proprietary mAb generating platform, DiversityTrap and ka …
  • PCI Pharma Services:製薬・医療:M&Aディール及び事業提携情報
    Summary PCI Pharma Services (PCI) is a pharmaceutical service provider that offers clinical, manufacturing and packaging solutions. The company offers clinical services such as clinical supplies management, clinical planning and support, project management, IVRS-IWRS, support services and data acces …
  • IntriCon Corp (IIN)-医療機器分野:企業M&A・提携分析
    Summary IntriCon Corp (IntriCon) is a designer, developer and manufacturer of miniature and micro-miniature body-worn medical and electronics products. The company’s products include glucose monitoring, medical coils, cardiac monitoring, amplifiers, systems, plastic medical molding, support products …
  • Ad Scientiam:企業の製品パイプライン分析
    Summary Ad Scientiam is a medical technology company that offers digital biomarkers which collects physiological and behavioral data. It provides mobile application which monitors patients’ behaviors and sharers the data to healthcare professionals. Ad Scientiam serves individuals, healthcare profes …
  • Heidelberger Druckmaschinen AG (HDD):企業の財務・戦略的SWOT分析
    Heidelberger Druckmaschinen AG (HDD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Humana Inc (HUM):企業の財務・戦略的SWOT分析
    Humana Inc (HUM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Natcore Technology Inc (NXT):電力:M&Aディール及び事業提携情報
    Summary Natcore Technology Inc (Natcore) is a solar research and development company that provides products for semiconductor and fiber optic applications. The company’s products include solar cell structures and black silicon cells. It uses liquid phase deposition technology for controlling deposit …
  • National Thermal Power Corporation Ltd:企業の戦略・SWOT・財務分析
    National Thermal Power Corporation Ltd - Strategy, SWOT and Corporate Finance Report Summary National Thermal Power Corporation Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Symic Biomedical Inc-製薬・医療分野:企業M&A・提携分析
    Summary Symic Biomedical Inc (Symic Biomedical) is a biopharmaceutical company that develops library of compounds that target and protect the ECM (extracellular matrix) from illness or injury-related degradation. The company’s ECM specific compounds facilitate local application, which enhances its a …
  • AeroParts Manufacturing & Repair, Inc:企業の戦略・SWOT・財務情報
    AeroParts Manufacturing & Repair, Inc - Strategy, SWOT and Corporate Finance Report Summary AeroParts Manufacturing & Repair, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Becker Avionics, Inc.:企業の戦略・SWOT・財務情報
    Becker Avionics, Inc. - Strategy, SWOT and Corporate Finance Report Summary Becker Avionics, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Noranda Income Fund (NIF.UN):企業の財務・戦略的SWOT分析
    Noranda Income Fund (NIF.UN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Cantabio Pharmaceuticals Inc (CTBO):製薬・医療:M&Aディール及び事業提携情報
    Summary Cantabio Pharmaceuticals Inc (Cantabio Pharmaceuticals) is a biotechnology company that concentrates on the commercializing of novel therapies for Parkinson’s disease, Alzheimer’s disease and neurodegenerative diseases. The company provide pipeline product candidates such as CB101 and CB102, …
  • Swiss Post Ltd:企業の戦略的SWOT分析
    Swiss Post Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Maruho Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Maruho Co Ltd (Maruho) carries out the research, development, production, and distribution of dermatological products. It product portfolio includes a wide range of prescription drugs, medical devices and other skincare products. The company also offers products for infectious disease, ear n …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆